bare-metal stent

AMP 2023

Design and MOA of the Bare Temporary Spur Stent System

12/05/2023

Watch as Dr. S. Jay Mathews, interventional cardiologist from Bradenton Cardiology Center in Florida, discusses his presentation at AMP 2023 on the Bare Temporary Spur Stent System (Reflow Medical), which is a unique approach to the...

Watch as Dr. S. Jay Mathews,...

12/05/2023

Vascular Disease Management

Original Contribution

Comparison Between Bare-Metal Stents, First-Generation Drug-Eluting Stents, and Bioresorbable Vascular Scaffolds

06/06/2021

Andrew Kei-Yan Ng , MBBS;

Pauline Yeung Ng , MBBS;

Chung-Wah Siu , MD;

Man-Hong Jim , MD;

The study objective is to compare the major adverse cardiovascular event rates after implantation of BVS, first-generation DES, and BMS.

The study objective is to...

06/06/2021

Journal of Invasive Cardiology

Comparison Between Bare-Metal Stents, First-Generation Drug-Eluting Stents, and Bioresorbable Vascular Scaffolds

06/01/2021

Man-Hong Jim , MD;

Andrew Kei-Yan Ng , MBBS;

Pauline Yeung Ng , MBBS;

Chung-Wah Siu , MD;

The study objective is to compare the major adverse cardiovascular event rates after implantation of BVS, first-generation DES, and BMS.

The study objective is to...

06/01/2021

Journal of Invasive Cardiology

Clinical Images

A Novel Approach to Aortoiliac Bifurcation Stenting Using a Single Balloon-Expandable Stent

12/28/2018

;

Rajiv Tayal , MD, MPH;

Najam Wasty , MD;

Mohammed E. Alomar , MD;

Marc S. Cohen , MD;

Contrary to popular wisdom, predominantly unilateral aortoiliac bifurcation disease can be safely treated with a single stent if the contralateral common iliac ostium is protected with matching balloon inflation.

Contrary to popular wisdom,...

12/28/2018

Journal of Invasive Cardiology

Original Contribution

Drug-Eluting vs Bare-Metal Stents in Patients With Chronic Kidney Disease and Coronary Artery Disease: Insights From a Systematic Review and Meta-Analysis

09/15/2017

Upendra Kaul , MD;

Mandeep S. Sidhu , MD;

Sripal Bangalore , MD, MHA;

Alexander Volodarskiy , MD;

Sunil Kumar , MD;

Radoslaw Pracon , MD;

Evgeny Kretov , MD;

Tomasz Mazurek , MD;

Olga Bockeria , MD;

This study evaluates the outcomes of drug-eluting vs bare-metal stent with implantation in patients with chronic kidney disease.

This study evaluates the...

09/15/2017

Journal of Invasive Cardiology

Original Contribution

Comparison of Drug-Eluting Stents With Bare-Metal Stents for PCI of Saphenous Vein Graft Lesions: Systematic Review and Meta-Analysis

11/15/2016

Michael E. Farkouh , MD, MSc;

Wassim Mosleh , MBBCh, BAO, MD;

Sumeet Gandhi , MD;

Mohamed Elsiddig , MBBCh, BAO;

Jon David Schwalm , MD, MSc;

The results of this large meta-analysis suggest that patients with DES (n = 39,213) in comparison with BMS implantation (n = 26,461) for PCI to SVG lesions had lower MACE, all-cause mortality, and TVR rates, without a significant reduction in...

The results of this large...

11/15/2016

Journal of Invasive Cardiology

Review

Bare-Metal Versus Drug-Coated Intracoronary Stents in Clinical Practice: Are There Guidelines?

09/18/2009

The development of bare-metal stents (BMS) and optimal post-procedure antiplatelet therapy in the mid 1990s resulted in marked reductions in acute and subacute stent thrombosis, bleeding complications, negative remodeling, and acute vessel...

The development of bare-metal...

09/18/2009

Vascular Disease Management